We are pleased to inform members about a successful online sharing session hosted by the HKAPI PSP Archetype for Hong Kong & DPMS Project Team on April 16th.
We are excited to share that approximately 120 members joined the recent seminar on Value-Based Medicine, hosted by HKAPI's catalyst member, Vista Health. The seminar focused on "Best Practices in Real-World Data: Perspectives from Outside of Hong Kong," providing valuable insights into the application of real-world evidence (RWE) in healthcare decision-making.
On February 25, the HKAPI Chronic Disease Co-Care Scheme (CDCC) & Community Drug Formulary (CDF) Project Team hosted an online sharing session with over 100 members participating.
On 29 November 2024, HKAPI jointly organized with Business Ethics Development Centre (BEDC) of Independent Commission Against Corruption (ICAC) and Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA) to hold a seminar on “Integrity Management Seminar for Executives of the Medical and Healthcare Industry”.
Aiming to develop an ecosystem for RWD, HKAPI and RDPAC co-organized “2024 GBA Real-world Research Forum” on 22 October, at the Guangzhou International Bio-Island.
"Developing Hong Kong as a Medical Innovation Hub," was held in collaboration with OASES. This event gathered prominent experts from Hong Kong's dynamic life and health technology sectors to showcase the city’s potential as a leading center for medical innovation.
The HKAPI HR Committee invited Baker McKenzie provides a valuable opportunity for members to delve into the complex and ever-evolving landscape of HR management on 16 August 2024
The HKAPI Regulatory Working Group recently co-organized a briefing session with the Department of Pharmacology and Pharmacy of HKU, on the "1+" mechanism and its enhancement measures on April 2024.
In response to members’ feedback following the announcement of the RDPAC-HKAPI Guidance on interactions with hospitals and HCPs in GBA, the HKAPI organized a training session in March 2024.